Rheosorbilact in complex intensive therapy of burn toxemia

Background. Thermal injuries primarily cause coagulation necrosis and cell death with vascular thrombosis in the areas of the deepest lesion. Objective. To study the effectiveness of rheosorbilact in infusion therapy during the period of burn toxemia. Materials and Methods. The results of monitor...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	G Khamraeva, Kh Mukhitdinova, G Alauatdinova
Formato:	article
Lenguaje:	RU UK
Publicado:	Interdisciplinary Academy of Pain Medicine 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/69f2f8975bcf4788b549afa7358534be
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:69f2f8975bcf4788b549afa7358534be
record_format	dspace
spelling	oai:doaj.org-article:69f2f8975bcf4788b549afa7358534be2021-11-24T01:29:54ZRheosorbilact in complex intensive therapy of burn toxemia10.31636/prmd.v4i2.42616-339X2617-2925https://doaj.org/article/69f2f8975bcf4788b549afa7358534be2021-11-01T00:00:00Zhttps://perioperative.org.ua/index.php/prtmdc/article/view/80https://doaj.org/toc/2616-339Xhttps://doaj.org/toc/2617-2925 Background. Thermal injuries primarily cause coagulation necrosis and cell death with vascular thrombosis in the areas of the deepest lesion. Objective. To study the effectiveness of rheosorbilact in infusion therapy during the period of burn toxemia. Materials and Methods. The results of monitoring the daily volume of the injected fluid, infusion therapy and renal excretory activity of 25 patients admitted to the Department of Combustiology of Republican Research Center of Emergency Medicine due to burn injury were studied. Results. The average daily volume of infusion therapy in group 1, FI – 119.4 ± 38.4 units at the age of 27.3 ± 5.6 years, was 76 ± 7 ml/kg per day, in group 2 (50.7 ± 7.1 years), FI – 92.5 ± 20.8 units, the introduction of 64 ± 9 ml/kg was effective, in group 3 (71.3 ± 7.0 years), FI – 86.7 ± 12.8 units, the introduction of an average of 48 ± 11 ml/kg per day was sufficient. In the nonlinear nature of changes in intravenous infusion, 4–5-day periods can be noted, probably due to the current factors that determined the need to increase or decrease infusion therapy. The introduction of rheosorbilact in a volume of 10 ml/kg per day increased the hourly renal excretory activity in all patients during the period of toxemia. The diuretic effect was more pronounced in patients of group 1, which corresponded to a greater volume of water load and the severity of burn injury. Conclusions. The introduction of rheosorbilact in a volume of 10 ml/kg per day increased the hourly renal excretory activity in all patients during the period of toxemia. G KhamraevaKh MukhitdinovaG AlauatdinovaInterdisciplinary Academy of Pain MedicinearticleMedicineRRUUKPerioperative Medicine, Vol 4, Iss 2 (2021)
institution	DOAJ
collection	DOAJ
language	RU UK
topic	Medicine R
spellingShingle	Medicine R G Khamraeva Kh Mukhitdinova G Alauatdinova Rheosorbilact in complex intensive therapy of burn toxemia
description	Background. Thermal injuries primarily cause coagulation necrosis and cell death with vascular thrombosis in the areas of the deepest lesion. Objective. To study the effectiveness of rheosorbilact in infusion therapy during the period of burn toxemia. Materials and Methods. The results of monitoring the daily volume of the injected fluid, infusion therapy and renal excretory activity of 25 patients admitted to the Department of Combustiology of Republican Research Center of Emergency Medicine due to burn injury were studied. Results. The average daily volume of infusion therapy in group 1, FI – 119.4 ± 38.4 units at the age of 27.3 ± 5.6 years, was 76 ± 7 ml/kg per day, in group 2 (50.7 ± 7.1 years), FI – 92.5 ± 20.8 units, the introduction of 64 ± 9 ml/kg was effective, in group 3 (71.3 ± 7.0 years), FI – 86.7 ± 12.8 units, the introduction of an average of 48 ± 11 ml/kg per day was sufficient. In the nonlinear nature of changes in intravenous infusion, 4–5-day periods can be noted, probably due to the current factors that determined the need to increase or decrease infusion therapy. The introduction of rheosorbilact in a volume of 10 ml/kg per day increased the hourly renal excretory activity in all patients during the period of toxemia. The diuretic effect was more pronounced in patients of group 1, which corresponded to a greater volume of water load and the severity of burn injury. Conclusions. The introduction of rheosorbilact in a volume of 10 ml/kg per day increased the hourly renal excretory activity in all patients during the period of toxemia.
format	article
author	G Khamraeva Kh Mukhitdinova G Alauatdinova
author_facet	G Khamraeva Kh Mukhitdinova G Alauatdinova
author_sort	G Khamraeva
title	Rheosorbilact in complex intensive therapy of burn toxemia
title_short	Rheosorbilact in complex intensive therapy of burn toxemia
title_full	Rheosorbilact in complex intensive therapy of burn toxemia
title_fullStr	Rheosorbilact in complex intensive therapy of burn toxemia
title_full_unstemmed	Rheosorbilact in complex intensive therapy of burn toxemia
title_sort	rheosorbilact in complex intensive therapy of burn toxemia
publisher	Interdisciplinary Academy of Pain Medicine
publishDate	2021
url	https://doaj.org/article/69f2f8975bcf4788b549afa7358534be
work_keys_str_mv	AT gkhamraeva rheosorbilactincomplexintensivetherapyofburntoxemia AT khmukhitdinova rheosorbilactincomplexintensivetherapyofburntoxemia AT galauatdinova rheosorbilactincomplexintensivetherapyofburntoxemia
_version_	1718416037867683840

Rheosorbilact in complex intensive therapy of burn toxemia

Ejemplares similares